RSPH Fact Sheet: Invesco S&P 500 Equal Weight Health Care ETF
Share
$39.91
close, Nov 18, 2026
Over the year to Nov 18, 2026, RSPH returned +29.7% in total and charged 0.40% a year.
- 1-year total return
- +29.7%
- to Nov 18, 2026
- Expense ratio
- 0.40%
- a year
- Net assets
- $1.0bn
- on Nov 17, 2026
- Net flow, last 5 trading days
- +$17.7m
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
RSPH $12,972 +29.7% · IVV $11,186 +11.9% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+3.2%
3 months+5.1%
Year to date+26.0%
1 year+29.7%
3 years+51.7%
5 years+35.9%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Moderna Inc2.29%
IDEXX Laboratories Inc2.02%
Mettler-Toledo International Inc2.00%
GE HealthCare Technologies Inc1.88%
Eli Lilly & Co1.88%
Viatris Inc1.86%
West Pharmaceutical Services Inc1.84%
McKesson Corp1.84%
Edwards Lifesciences Corp1.83%
Intuitive Surgical Inc1.83%
RSPH top ten by weight, 19.3% of the fund, of its 63 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the S&P 500 Equal Weight Health Care Index · First traded Nov 7, 2006 · Benchmark Its own holdings, as of Nov 17, 2026